Brooklyn ImmunoTherapeutics, Inc. - Common Stock (BTX)

Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below.

Today, BlackRock Resources & Commodities Strategy Trust (NYSEBCX), BlackRock Enhanced Equity Dividend Trust NYSE: BDJNYSEBDJ)(NYSE: BGRNYSEBGR, BlackRock Enhanced International Dividend Trust (NYSE: BGYNYSE), BlackRock Health Sciences Trust (NYSE: BMEBME), BlackRock Health Sciences Term Trust (NYSEBMEZ), BlackRock Enhanced Global Dividend Trust NYSE: BOENYSEBOE)(NYSE: BUINYSEBUI, BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CIINYSE), BlackRock Science and Technology Trust (NYSE: BSTBST), BlackRock Science and Technology Term Trust (NYSEBSTZ), BlackRock Technology and Private Equity Term Trust NYSE: BTXNYSEBTX)(NYSE: BCATNYSEBCAT, and BlackRock ESG Capital Allocation Term Trust (NYSE: ECATNYSE) (collectively, the “Funds”) paid the following distributions per share:

The BlackRock closed-end funds listed below (each, a “Fund” and collectively, the “Funds”) announced today the renewal of their discount management programs (each, a "Program" and collectively, the “Programs”). Under the terms of each Fund’s Program, each Fund intends to offer to repurchase a portion of its common shares via tender offer if certain conditions are met during the specified time period, as detailed below.